Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive

Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive — Trials · CancerIndex

Clinical trials

Registered studies

95 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 14
Recruiting: 7
Ph III recruiting: 0
Growth YoY: —
Industry share: 7%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 46.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–49 of 49 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03147612	Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia	active not recruiting	Phase 2	22	M.D. Anderson Cancer CenterOTHER	1	Aug 19, 2026	clinicaltrials
NCT03934372	Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors	recruiting	Phase 1 / Phase 2	70	Incyte Biosciences International SàrlINDUSTRY	7	Jul 23, 2026